top of page
Pain Cloud.png

Pain Cloud® is our B2B platform using the Personalized Analgesics®  in-silico network biology research 

Increase your POS in a cost efficient and quick way replacing the high-cost and long-timeline traditional R&D paradigm.

Traditional R&D
Over-reliance on non-translatable pre-clinical models, and clinical development in market-size determined patient groups that have limited links to the research target, cause the 99% failure rate

PA overview.png

BROAD APPLICATION SPACE ALONG THE VALUE CHAIN

Pain Cloud® uses the Personalized Analgesics® research to match targets and mechanisms with the optimal patient group; e.g., allowing stratification for clinical development. 


This significantly de-risks clinical development, as well as enables identifying novel applications for existing medicines, creating market extension and innovative re-purposing opportunities.

WORKING TOGETHER TO TRANSFORM HOW PAIN IS TREATED

B2B.png

Utilise our novel research techonolgy to increase POS of your R&D projects

  • Precisely matching targets to phenotypes;

  • Through B2B platform enabled network biology ‘diseasomics’, 

  • Developing in stratified patients, selected from >1,000 conditions, 

  • Creating flexible partnership structures.

Contact

Contact us to find out more...

bottom of page